|
As reported, a 7f avanti+ w/gw no obt sheath introducer was opened and noticed an oily substance around the hub area.There was no reported patient injury.Additionally units with the same lot number were removed but not confirmed to be damaged.There was not any damage noted to the packaging.There were not any other anomalies noted to the device upon opening.The package was completely sealed.The entire lot associated with this device was pulled for precaution.After further review, per the sales rep, "it seems as though they all are somewhat oily.It is not visible but to the touch it feels it." all 10 devices will be returned for evaluation.Further clarification was received from the sales rep stating "one was used in the case when they noticed the oily substance and discarded it.Of the remaining devices, not all were opened.When they were delivered, only 2 had been opened of the 24 devices returned.".
|
|
After further review of additional information received the following (event, pma/510k, if follow-up, what type, device evaluated by mfr and adverse event problem) have been updated accordingly.This report is related to 9616099-2019-03133.Two 7f avanti + 7f std w/gw no obt catheter sheath introducers (csi) were opened and an oily substance around the hub area was noticed.One of the devices was used in a case when they noticed the oily substance.There were eight additional units with the same lot number that were pulled for precaution but not confirmed to be damaged.There was no reported patient injury.There was no damage noted to the packaging.There were no other anomalies noted to the device upon opening.The packages were completely sealed.It seems as though they all are somewhat oily.It is not visible but to the touch it feels it.One of the two opened devices was discarded, and the other device is available for analysis.A non-sterile avanti + 7f std w/gw no obt along with a mini guidewire and vessel dilator were returned for analysis inside a plastic bag.Per visual analysis, an oily substance was observed on the surface of the csi valve.No other anomalies were observed.In addition, eight sterile units of avanti + 7f std w/gw no obt were received inside of a plastic bag.The seals of all the product packaging were intact.The integrity of the sterile pouches was not compromised.The returned units show an oily substance on the valve of the csi.No other anomalies were observed on the returned product.Infrared spectroscopy (ftir analysis) identification technique was performed to the non-sterile unit to determine the composition of the oily substance observed on the csi valve received.The ir spectrum obtained from the csi valve showed that valve is made of polyethylene and the oily substance was identified as mdx fluid; since characteristic ir bands were found on the spectrum corresponding to this material.Mdx fluid is a lubricant usually applied to csi valves during manufacturing process.A product history record (phr) review of lot 17833744 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The second opened device was not returned for analysis.A product history record (phr) review of lot 1783374 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿packaging/pouch/box - foreign material in sterile package¿ was not confirmed through analysis of the returned device since the material (mdx) is inherent to the manufacturing process of the device and not considered foreign.However, as the customer is not aware of the manufacturing process of the unit, this material could appear as foreign, and the presence of the substance was confirmed.It should be noted that the mdx fluid is biocompatible, and these devices are safe to be used with the fluid.The medical fluid is intended to lubricate the interaction between the vessel dilator and the gasket component.According to the instructions for use, which is not intended as a mitigation of risk, ¿do not use if package is open or damaged.¿ standard clinical practice calls for inspection of the device and packaging prior to use in the patient.If the user notes anything unusual, they are urged to discontinue use of the device and exchange for another.Neither the phr review, the procedure films nor the product analysis suggests that the event experienced by the customer could be related to the manufacturing process; therefore, no corrective/preventive action will be taken at this time.
|